Posted in | News | Energy | Automotive Materials

Innovative New Energy Absorbing Bumpers Offer Greater Pedestrian Protection

A-segment cars, also known as city cars, are growing in popularity due to their fuel-sipping benefits. But the very small size of these vehicles poses challenges to designers, so when designers of the Hyundai i10 – a city car produced by Hyundai Motor India Limited (HMIL) and targeted for export – were tasked with creating an energy absorber (EA) that would meet stringent European safety regulations for pedestrian lower leg impact, they faced space constraints for the EA, which required an alternative to bulky expanded polypropylene (EPP) foam. Based on Hyundai’s collaboration with SABIC Innovative Plastics on the QarmaQ Advanced Technology Demonstration Vehicle and the development of its Elastic Front safety system concept, HMIL selected Xenoy* polycarbonate/polybutylene terephthalate (PC/PBT) alloy. Because of the superior energy absorption efficiency of Xenoy resin compared to EPP, the HMIL team was able to comply with the EU requirements within the allotted space.

“Small city cars like the Hyundai i10 call for innovative materials that give designers greater flexibility and strength when space is at a premium,” said Umamaheswaran Venkatakrishnan, India Automotive director for SABIC Innovative Plastics. “Our technology team in Bangalore worked closely with HMIL and Hanilehwa, the EA supplier, to provide the best material for compliance with safety requirements, and to optimize the part design for top performance. Our side-by-side, long-term collaboration with automotive customers helps them deliver business success.”

With the revised EA design featuring Xenoy resin, the Hyundai i10 qualified for export to the EU. Further, it won the 2008 Indian Car of the Year award and a host of other honors. Within three months following i10’s European debut at the Bologna Motor Show in December 2007, HMIL achieved total sales of 196,632 vehicles. This comprised of 99,595 units from domestic sales and an additional 97,037 units coming from export.

Higher Energy Absorption Efficiency to Meet EEVC, WG17 Phase II Requirements

Xenoy resin provided several performance advantages over EPP that allowed Hyundai to comply with Phase II of the EU’s pedestrian safety standard. First, the resin provides 60-70 percent energy absorption efficiency compared to about 45 percent for EPP; this means Xenoy resin requires less space to deliver the required performance. It easily provided sufficient energy absorption within the very tight 45 mm space allotted by the EA design.

Second, the SABIC Innovative Plastics material delivers better performance than EPP at temperature extremes from -30C to 60C. Xenoy resin’s performance deviation is less than 10 percent, compared to close to 40 percent for the foam.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    SABIC Innovative Plastics. (2019, February 10). Innovative New Energy Absorbing Bumpers Offer Greater Pedestrian Protection. AZoM. Retrieved on April 20, 2024 from https://www.azom.com/news.aspx?newsID=16091.

  • MLA

    SABIC Innovative Plastics. "Innovative New Energy Absorbing Bumpers Offer Greater Pedestrian Protection". AZoM. 20 April 2024. <https://www.azom.com/news.aspx?newsID=16091>.

  • Chicago

    SABIC Innovative Plastics. "Innovative New Energy Absorbing Bumpers Offer Greater Pedestrian Protection". AZoM. https://www.azom.com/news.aspx?newsID=16091. (accessed April 20, 2024).

  • Harvard

    SABIC Innovative Plastics. 2019. Innovative New Energy Absorbing Bumpers Offer Greater Pedestrian Protection. AZoM, viewed 20 April 2024, https://www.azom.com/news.aspx?newsID=16091.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.